Eligibility for GLP-1 RA therapy for weight management was defined as: (1) BMI 30 kg/m 2 , or (2) BMI 2729.9 kg/m 2 with at least one documented weight-related comorbidity (arterial hypertension, coronary artery disease, hypercholesterolemia, or sleep apnea)
This indicates that oral GLP-1 medications can be a viable option for individuals struggling with obesity
Whether that margin justifies the higher side effect burden is a personal calculation
Replenza is designed to help nourish from within and is made with amino acids, prebiotics, probiotics and essential nutrients. Speaking to The Post, Dietitian and Replenza Advisory Board Member Danielle Schupp stressed the importance of nourishment and nutritional support for those taking GLP-1 medications
The thigh This location is preferable for self-administrated shots
Rybelsus is ideal for adults with Type 2 diabetes who: Struggle with achieving blood sugar control through other medications or lifestyle changes